000756 新華製藥
按盤價 
15.700 -0.820 (-4.964%)
15.700 -0.820 (-4.964%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 7.302 | 11.441 | 10.826 | 10.417 | 10.490 |
| 總資產報酬率 ROA (%) | 4.022 | 6.000 | 5.271 | 4.833 | 4.802 |
| 投入資產回報率 ROIC (%) | 4.943 | 7.422 | 6.631 | 6.113 | 5.598 | 邊際利潤分析 |
| 銷售毛利率 (%) | 23.496 | 29.524 | 27.154 | 27.037 | 30.215 |
| 營業利潤率 (%) | 5.914 | 6.599 | 6.354 | 6.488 | 7.035 |
| 息稅前利潤/營業總收入 (%) | 5.986 | 6.778 | 6.715 | 7.228 | 8.248 |
| 淨利潤/營業總收入 (%) | 5.278 | 6.248 | 5.679 | 5.519 | 5.780 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 101.059 | 106.994 | 102.275 | 91.717 | 102.157 |
| 價值變動淨收益/利潤總額(%) | 2.138 | 1.799 | 1.773 | 1.903 | 1.363 |
| 營業外收支淨額/利潤總額(%) | -1.362 | -0.356 | -1.045 | -1.034 | -2.635 | 償債能力分析 |
| 流動比率 (X) | 1.343 | 1.333 | 1.094 | 1.101 | 1.128 |
| 速動比率 (X) | 0.874 | 0.805 | 0.711 | 0.690 | 0.656 |
| 資產負債率 (%) | 42.251 | 42.365 | 47.372 | 50.203 | 52.188 |
| 帶息債務/全部投入資本 (%) | 29.357 | 28.633 | 35.112 | 24.727 | -- |
| 股東權益/帶息債務 (%) | 229.615 | 237.510 | 175.807 | 245.469 | 200.379 |
| 股東權益/負債合計 (%) | 130.658 | 129.703 | 105.390 | 94.215 | 87.090 |
| 利息保障倍數 (X) | 39.467 | 33.578 | 15.734 | 8.962 | 5.917 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 33.504 | 32.466 | 34.062 | 28.494 | 0.000 |
| 存貨周轉天數 (天) | 67.562 | 79.608 | 73.754 | 80.926 | 0.000 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 22/11/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
